![Methyl 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoate](https://static.cymitquimica.com/products/3D/img/FM41972.png "Click to enlarge")
Methyl 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoate
CAS: 155405-80-4
Ref. 3D-FM41972
| 1g | 97.00 € | ||
| 2g | 156.00 € | ||
| 5g | 195.00 € | ||
| 10g | 351.00 € | ||
| 25g | 554.00 € |
Product Information
- 1H-Pyrrolo[2,3-d]pyrimidine, benzoic acid deriv.
- Methyl 4-[2-(2-Amino-4-Oxo-1,7-Dihydropyrrolo[4,5-E]Pyrimidin-5-Yl)Ethyl]Benzoate
- Methyl 4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoate
- Methyl 4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoate
- Methyl 4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoate
- benzoic acid, 4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]-, methyl ester
- benzoic acid, 4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]-, methyl ester
Methyl 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoate is a prodrug that is hydrolyzed to form the active drug pemetrexed disodium. The drug has been shown to be effective for the treatment of cancer and has been used in clinical trials for patients with lung cancer. The conversion of this prodrug to its active form occurs through a hydrolysis reaction at high temperature and by saponification with sodium hydroxide. Methyl 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3 - d]pyrimidin -5 -yl)ethyl)benzoate can also be converted into its active form by enzymatic action using ester
Chemical properties
Technical inquiry about: 3D-FM41972 Methyl 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
